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a b s t r a c t
Photodynamic Therapy (PDT) is a local treatment that requires a photosensitizing agent, light and
molecular oxygen. With appropriate illumination, the photosensitizer is excited and produces singlet
oxygen that is highly reactive and cytotoxic. Tumor vascular network is essential for the tumor growth
and the understanding of vascular response mechanisms enables an improvement in the PDT protocol
for cancer treatment. Compounds of porphyrin (Photogem) and chlorin (Photodithazine) were the
photosensitizers tested. The incubation times varied from 20 to 80 min and the concentration ranged
between 0.1 and 100 lg/cm2. Different light doses were used between 4.8 and 40 J/cm2 with irradiance
varying between 80 and 100 mW/cm2. The light dose of 30 J/cm2 was used in the intravenous photosen-
sitizer application. The membrane images were made from 0 to 300 min after treatment. The vascular
response was evaluated by the average vessel area. Different responses was observed depending on
the photosensitizer concentration and administration form. Intravenous application has been more efﬁ-
cient to produce vessel constriction and the most pronounced effect was observed for the chlorin.
 2014 Elsevier B.V. All rights reserved.
1. Introduction
Angiogenesis is the phenomenon that involves a new blood
vessel formation and is intrinsically linked to several diseases, such
as cancer, rheumatoid arthritis and psoriasis [1,2]. In 1971, Folkman
described the relation between this phenomenon and cancer. He
showed that angiogenesis is essential for both tumor growth and
metastasis. This new vascular network development happened to
feed the tumor [3]. Therefore, the knowledge about the tumor
growth involves the elucidation of its biological properties, includ-
ing new vessels generation from a pre-existing vascular network
[4–7].
A well established model to study angiogenesis uses chicken
eggs [8,9]. In the chicken eggs there are porous and rigid eggshell
and inner and outer membranes that are permeable to oxygen, car-
bonic gas and water vapor [10,11]. Due to the need of oxygen for
the embryo development, there is the formation of chorioallantoic
membrane that is a fusion of the allantoic (responsible for respira-
tion) and chorio (membrane that involves embryo and its struc-
tures). This membrane is beneath the porous shell; it presents a
lot of vessels and enables enhanced gas exchange [12–14]. The
chorioallantoic membrane of chicken eggs is known as CAM and
is probably the most used in vivo model to study angiogenesis
and compounds activities in vascular endothelium. With a direct
access to blood vessels and embryo, this model is simple, cheap
and of easy implementation in laboratory environment [15–17].
The scientiﬁc community has searched for alternative tech-
niques for oncologic treatments when traditional treatments are
inefﬁcient or present limited responses [18,19]. Photodynamic
Therapy (PDT) is a treatment modality which involves light (at spe-
ciﬁc wavelength), a photosensitizing agent and molecular oxygen.
The photosensitizer (PS) in tumor cells is activated by light and
interacts with cell oxygen, resulting mainly in the production of
singlet oxygen, a highly reactive species that induces damage to
biomolecules [20–22].
Several groups that work with PDT have invested in the devel-
opment of improved photosensitizers. Ideal characteristics for the
photosensitizer are low dark toxicity, high efﬁciency for singlet
oxygen generation, high penetration by cell membranes and fast
post-treatment clearance [23–29]. Other relevant characteristics
are needed to a molecule become a clinical photosensitizer, such
as a long life-time of the excited triplet state and high molar absor-
bance at the electromagnetic ‘‘therapeutic window’’ between
600 nm and 1000 nm, where the light show a measurable penetra-
tion into the biological tissues [30–33].
Actually, compounds of porphyrin, chlorin, bacteriochlorin,
phthalocyanine and others have been applied with success in
PDT, but their individual mechanisms and the resulted differences
on the photodynamic response are still not complete understood.
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The chlorin compounds are classiﬁed as photosensitizers of sec-
ond-generation and have higher molar absorbance at the red spec-
trum that results in higher PDT response with the use of lower
energy doses. Chlorins are replacing the porphyrin derivatives that
are classiﬁed as ﬁrst-generation compound [34].
Among hematoporphyrin compounds, the most related one in
literature is Photofrin (Photofrin, USA) while for chlorin com-
pounds, there is Foscan (Foscan, Ireland). With these photosensi-
tizers there are several protocols with illumination, ranging from
33 mW/cm2 to 150 mw/cm2, and doses of 5, 10, 50 and 100 J in
CAMmodel [25].
Tumor vascular network is responsible for delivering the nutri-
ents, oxygen and the photosensitizer to the neoplastic cells. Both
tumor survival and the PDT response are inherently dependent on
vascularization characteristics and any changes in the vascular net-
work can affect the further PDT response. With the CAMmodel, we
can study individually the vascular effect of PDT, helping to analyze
the tissue damage. It is possible to vary several parameters associ-
ated with this therapy, as drug type and concentration, photosensi-
tization via, drug-light interval, light dose, ﬂuence and irradiance.
The PDT vascular response can be evaluated according to the vessel
diameter and extension, post-PDT time interval and embryo age.
The understanding of vascular response mechanisms enables an
improvement in the PDT protocol for cancer treatment. [23,35,36].
The PDT injury at the blood vessels is particularly useful in the
treatment of malignancy since cancer lesions recruit new small
immature vessels for the supply of nutrients and, although this phe-
nomenon has not been extensively studied, PDT has shown to cause
thrombosis of smaller vessels. However, it is necessary to observe
the major blood vessels that are in close proximity to tumor that
are extremely important to the life of the patient. For example, in
cases of head and neck cancer there is the carotid artery that needs
to be preserved. Fatal cases of hemorrhage caused by PDT had been
related, showing the relevance of the knowledge of different
response to use of different photosensitizers. The evaluation of the
PDT vascular response in an animal model is complex, since the
tumor overall response is a combination of the damage in cells,
extracellular matrix, and vessels. The determination of the induced
vascular response for different photosensitizers may improve the
safety of the present PDT clinical protocols [37–40].
In this context, the aim of this study was to evaluate the vascu-
lar effect of PDT on the CAM model when two different types of
photosensitizers are used under different protocols.
2. Materials and methods
2.1. CAM model
Chicken eggs obtained from a local producer (GLOBOAVES, São
Carlos/SP, Brazil) were used for the experiments. On the ﬁrst day of
fecundation, embryo eggs were wiped with 70% alcohol tissue
before being placed in an incubator at 37.7 C. During the ﬁrst
and second days of development, the eggs were kept under con-
stant slow rotation motion – half cycle each 30 min. On the third
day, a small hole was produced with a hand driller in the shell
for the removal of 3–4 mL of albumin with a syringe and the rota-
tion was interrupted. A window of 2 cm2 was opened on the fourth
day and sealed with adhesive tape until 11th day. The survival rate
of the CAM model obtained was of 60%. For each PDT protocol, 3–5
eggs were used to verify the response.
2.2. Photosensitizers
Two photosensitizers (PS) were used: a porphyrin compound
(Photogem, Photogem, Russia) and a chlorin compound (Photo-
dithazine, Veta Grand, Russia). Their structures are showed in
Fig. 1a [41] and Fig. 1b [42], respectively.
The PS concentration ranged from 0.1 to 100 lg/cm2. A stock
solution was prepared using 5 mg of Photogem diluted in 1 mL of
distilled water and the stock solution of Photoditazine also was
5 mg/mL. Both were diluted in distilled water to obtain the desired
ﬁnal concentration.
2.3. Topical administration
Both PS were topically administered to the vascular network of
the eggs. A 15 mm Teﬂon ring was used to delimit the target site
(1.76 cm2) in the vascular network. 200 lL of the PS solution was
gently placed inside the ring using a pipette. The times of incuba-
tion investigated were of 20, 40, 60 and 80 min to determine the
best interval for each PS. After the incubation time, the photosen-
sitizer solution was removed by a syringe and the area inside the
ring was washed with a 0.9% NaCl solution.
2.4. Intravenous administration
Photogem and Photodithazine were intravenously adminis-
trated by an insulin syringe with a 29G gauge needle. The egg
was a little rotated until the central blood vessel had become
slightly stretched. The inject was performed with the gauge angled
at approximately 45 and the Teﬂon ring placed to delimit the
area of illumination. The tested concentrations of PS were 0.2, 0.5
and 5 lL/cm2 and the injected volume was 500 lL.
2.5. Photodynamic Therapy
Two diode lasers (EagleEaron, Quantum Tech, Brazil) were
used as light sources, one emitting at 630 nm, for Photogem,
and the other at 660 nm for Photodithazine. The light was deliv-
ered via an optical ﬁber whose lenses were coupled to the tip so
that a uniform irradiation proﬁle could be obtained. The illumina-
tion ﬁber was assembled on a support to ﬁx the distance between
ﬁber tip and egg membrane to obtain an illumination area of the
size of the ring area.
The induced vascular changes were ﬁrst evaluated under differ-
ent conditions for the establishment of safe parameters to the
embryonic annexes (egg white, yolk and embryo). No changes
were observed with illumination from 4.8 to 40 J/cm2 and irradi-
ance at 80, 100 and 120 mW/cm2, which resulted in illumination
time between 80 and 300 s. After this analysis, the irradiance
was set at 100 mW/cm2 and ﬂuence of 30 J/cm2.
Based on the results obtained with topical Photogem, an irra-
diance of 100 mW/cm2 was set for topical chlorin and the tests
were conducted with 300 and 600 s, resulting in ﬂuences of 30
and 60 J/cm2, respectively.
Fig. 1. Structures of photosensitizers used. (a) Photogem. (b) Photodithazine.
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Two types of energy delivery were tested for the topical PDT:
continuous and fractionated (1/1 min with light/dark cycles) for
both PS. For the intravenous PS application, the illumination was
performed during, immediately after, one minute and ﬁve minutes
after injection.
2.6. Control groups
Treatment control groups were performed to evaluate the vas-
cular effect of the light and the PS. The dark toxicity of both photo-
sensitizers was evaluated by monitoring the vascular network after
40 min of incubation time at 1 lg/cm2. The same procedure of the
PDT group was repeated without the illumination. The illumina-
tion effect was analyzed for both excitation wavelengths, under
100 mW/cm2 and 30 J/cm2. The inﬂuence of the injection proce-
dure was evaluated after the injection of a saline solution at the
same total volume. In all tests, the vascular network was moni-
tored until 300 min after treatment.
2.7. Evaluation of the photodynamic vascular response
Images were captured every 30 min after illumination until
300 min with a USB Digital Microscope (AVANTGARDE, China).
They were processed by Photoshop software (ADOBE PHOTOSHOP
CS4, version 11, USA). The pixels corresponding to vessels were
deﬁned as black and the remaining structures as white pixels
(embryo, yolk and egg white). To quantify the overall vascular
response, the decrease or increase in the total area of blood vessels
was calculated using a percentage of black pixels in the region of
interest as a function of time. This analysis was performed using
the ImageJ software (National Institutes of Health, USA, public
domain).
A maximum increase and minimum decrease in the total
amount of blood vessels were calculated from the maximum and
minimum percentage values of black pixels normalized for the ini-
tial value (t = 0). The maximum diameter of the damage vessels
was determined for each PDT condition.
The vessel diameters were deﬁned by calibrating the pixels
with the ﬁxed measurement of ring width. Using this analysis, a
correlation between the vessel diameter and the ﬁnal changes after
the PDT could be established for each protocol.
3. Results and discussion
The analysis of vascular damage using PDT in CAM presented in
the literature is usually based on a score method. This kind of
method depends of the vessel diameter and if there is a total occlu-
sion, partial occlusion or no occlusion. This score ranges from zero
to ﬁve or in relative arbitrary units. The analysis shows the
response at speciﬁc vessels, giving a local response, but lacking
studies presenting a vasculature overall effect.
The blood vessel quantiﬁcation in CAMmodel is a complex prob-
lem and several methods can be used aiming a best analysis. Varia-
tions involve image acquisition and its processing, with several
computational or manual methods. In the literature, it is possible
to highlight the restriction of visual ﬁeld and manual counting of
blood vessels, analysis of individual parameters, methods using
fractal analysis, among others methods.
The quantiﬁcation of small changes in the vascular network is
the main difﬁculty of the proposed methods, since this counting
is manual. Furthermore, some alternatives of image acquisition
are done using microscopes however, this analysis requires the
CAM removal and prevents the monitoring of the vascular damage
over time [43]. The use of binary image is already known using sev-
eral methods, including the fractal dimensional method [44–46].
Our analysis was based on the overall vascular response, quan-
tifying the vessel pixels with image acquisition before and after the
treatment, in the total illuminated area. This procedure involved
the area inside the Teﬂon ring and the number of pixel is directly
related to the area of blood vessels. A qualitative analysis was also
performed to determine the relation of the individual vessel
response, depending on its diameter and the PDT protocol.
3.1. Topical administration
For all incubation times tested, the results showed that 40 min
was an appropriate drug light interval, because shorter times did
not induce any alteration in the vascular network and longer times
provided similar results.
The analysis of the control treatment groups, where the toxicity
of only light or PS was investigated, revealed no major changes in
the vascular network and the illumination and PS parameters,
when applied individually, induce no vascular damage.
3.1.1. Porphyrin
Setting the incubation time at 40 min and ﬂuence at 30 J/cm2,
the initial concentration tested was of 1 lg/cm2. The images of
the vascular network after PDT (Fig. 2a) were processed for a quan-
titative analysis. The ratio of black/white pixels was calculated for
each image, resulting in the total blood vessel area as a function of
time (Fig. 2b).
Fig. 2a shows vascular damage at 150 min and a more pro-
nounced effect at 300 min after PDT, indicating that the parame-
ters were effective to induce vessels destruction.
A decrease in the CAM overall vascularization due to vessel
shutdown or a reduction in its diameter could be observed.
From the graphs of Fig. 2b, the average reduction was calculated
for the three eggs treated using the same PDT parameters, and the
result is a decrease of 66% ± 17%. Each egg shows an initial different
network and therefore an individual analysis was performed. The
average value shows a signiﬁcant and general vessels reduction.
The correlation between the vessel diameter and the PDT
response was established for diameters between 3 and 360 lm. In
wider vessels (over 151 lm) a vascular constriction was observed,
with a diameter reduction between 30% and 70%. Thinner vessels
(below 144 lm) exhibited completed destruction.
The Photogem concentration was increased to 100 lg/cm2 to
evaluate if the vessel destruction could be improved. With higher
PS concentration, there is more drug availability for cells.
Fig. 2c shows that after PDT the peripheral vessels became more
pronounced, due to a vessel dilatation in this region. A qualitative
analysis suggests an increased vascular network resulted from the
appearance of thin vessels, not evident immediately after treat-
ment (zero time). No angiogenesis occurred due to the short inves-
tigation time when the event was observed. These thin vessels
were already present in the CAM, but with no active function, since
no blood was inside them. After PDT, which occurred in the thicker
vessels, that retained higher concentrations of the photosensitizer,
the damage was induced in the vessel wall resulting in the con-
striction, and ﬁnally the blood ﬂow was directed to other vessels,
that were not previously required in the vascular network.
Through image processing, the graph of Fig. 2d shows this behav-
ior quantitatively. The graphs shows maximum values of reduction
of (10% ± 3%) and increase of (20% ± 10%), calculating from the aver-
age of three eggs.
The measurements of vessel diameter revealed that vessels
whose diameter above 143 lm suffered a decrease of approxi-
mately 30%. Vessels measuring above 447 lm did not undergo
any change. In deeper layers, no changes were observed in larger
vessels, however, narrow vessels measuring less than 52 lm
showed dilatation.
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3.1.2. Chlorin
The same parameters applied to porphyrin were used with a
chlorin, starting with concentration of 1 lg/cm2. A sequence of
images is provided in Fig. 3a, with pixel transformation image
and plot of blood vessel area as a function of time (Fig. 3b).
A qualitative analysis of the vascular effect induced by PDT
using chlorin at 1 lg/cm2 showed a very similar behavior to por-
phyrin when used at 100 lg/cm2.
This behavior, suggests a faster photodynamic response of the
chlorin compound in the larger vessel in comparation to the por-
phyrin compound. If a vascular damage had occurred more slowly,
there would be enough time for a vessel activation and dilation in
the peripheral environment.
The calculated average reduction was of (15% ± 5%) and increase
of (15% ± 2%), showing no signiﬁcant overall vascular change in the
network area, similar to the one observed with Photogem at
100 lg/cm2. In the analysis of the vessel diameter, vessels smaller
than 230 lm were completely destroyed in some regions over the
investigated time post therapy. Vessels between 230 lm and
402 lm suffered a diameter reduction of approximately 30% and
70%. Vessels whose diameter was larger than 402 lm or in deeper
layers showed a reduction of 30% or less. The dilatation happened
with vessels smaller than 49 lm.
From these results, a lower concentration of chlorin at 0.1 lg/
cm2 was tested, reducing the availability of this PS. The images
in Figs. 3c clearly show a reduction in the vascular network diam-
eter after PDT. This result is similar to the one obtained when
Photogem was used at 1 lg/cm2 (Figs. 2a and b). From the image
processing for the quantitative analysis the graph in Fig. 3d was
plotted, comproving this similar behavior. The average of 3 eggs
testing the same parameters resulted in a reduction of 43% ± 9%
and increase of 10% ± 4%, in vessel diameter.
For chlorin at 0.1 lg/cm2, vessels thinner than 156 lm were
completely destroyed while wider vessels suffered only a reduc-
tion of 30–60%. All results are summarized in Table 1.
When both photosensitizers topically applied were compared,
two main observations could be pointed: equivalent effect of por-
phyrin and chlorin at different concentrations and distinct vascular
for the same compound, depending on its concentration. The similar
behaviors of porphyrin and chlorin at different concentrations were
qualitatively and quantitatively observed. Considering the overall
vascular effect, chlorin has been the most efﬁcient compound, since
a faster effect occurs with lower concentration when compared to
porphyrin. This probably occurs because Photodithazine has smal-
ler molecules than Photogem that is a mixture of oligomers of sev-
eral sizes, increasing the time of diffusion between the CAM layers.
Therefore, chlorinmolecules penetrates in the CAM faster andmore
deeply and a higher amount of the PS will be available to both the
endothelial cells and the blood. If there is more PS in the cell and
in the blood ﬂow, and the photons are delivered there with the illu-
mination, then a higher PDT effect will be present.
3.2. Intravenous administration
For intravenous injection, the illumination performed at imme-
diately after, 1 min and 5 min after injection, no or only small
changes were induced in the vascular network. This occurs because
the PS is taken by the blood ﬂow and is not absorbed by the
Fig. 2. PDT response with porphyrin and topical application. (a) 1 lg/cm2 – images of CAM as a function of post-treatment time and corresponding processed images. (b)
1 lg/cm2 – graph of the ratio of black/white pixels. (c) 100 lg/cm2 – images of CAM as a function of post-treatment time and corresponding processed images. (d) 100 lg/cm2
– graph of the ratio of black/white pixels.
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endothelial cells within those drug-light intervals. Under such con-
ditions, no photodynamic effect occurs. The vascular effect was
observed only when the illumination was performed during the
intravenous injection of the PS. It is important to highlight that
when the needle is removed from the vessel, the resulting bleeding
was intense and prolonged, no images could be acquired. Therefore
only eggs with small bleeding were considered for the image pro-
cessing analysis.
3.2.1. Porphyrin
500 lL of solution with concentration of 0.2 mg/mL were slowly
injected, and during this processes, a ﬂuence 30 J/cm2 was deliv-
ered. The injection lasted approximately 2 min and the total illumi-
nation was performed in 5 min. An evident acute vascular
shutdown was observed in Fig. 4a. With the graph in Fig. 4b, the
reduction of the vascular network area was calculated in
73% ± 20%.
Fig. 3. PDT response with chlorin and topical application. (a) 1 lg/cm2 – images of CAM as a function of post-treatment time and corresponding processed images. (b) 1 lg/
cm2 – graph of the ratio of black/white pixels. (c) 0.1 lg/cm2 – images of CAM as a function of post-treatment time and corresponding processed images. (d) 0.1 lg/cm2 –
graps of the ratio of black/white pixels.
Table 1
Summarized vascular response for the PDT protocols used.
Administration PS Concentration Total decrease (em %) Total increase (em %) Behavior of vessel after PDT Vessel diameter
Topical Porphyrin 1 lg/cm2 66 ± 17 9 ± 6 Total constriction <151 lm
Reduction between 30% and 70% >151 lm
Reduction of up to 30% – deeper layers >153 lm
Chlorine 1 lg/cm2 15 ± 5 15 ± 2 Total constriction Absent*
Reduction between 30% and 70% >230 lm
Reduction of up to 30% >402 lm
Reduction of up to 30% – deeper layers >333 lm
Dilatation <49 lm
Porphyrin 100 lg/cm2 10 ± 3 20 ± 10 Total constriction Absent*
Reduction between 30–70% >143 lm
Reduction of up to 30% >447 lm
Reduction of up to 30% – deeper layers >150 lm
Dilatation <52 lm
Chlorine 0.1 lg/cm2 43 ± 9 10 ± 4 Total constriction <156 lm
Reduction between 30% and 70% >156 lm
Intravenous Porphyrin 0.2 mg/mL 59 ± 13 3 ± 2 Total constriction <186 lm
Reduction of up to 30% – deeper layers >186 lm
Reduction between 30% and 70% >186 lm
Chlorine 0.2 mg/mL 73 ± 20 10 ± 10 Total constriction <351 lm
Reduction of up to 30% – deeper layers >351 lm
* There was no destruction because it was possible to observe regions of total occlusion, but not the complete vessel occlusion.
H.H. Buzzá et al. / Journal of Photochemistry and Photobiology B: Biology 138 (2014) 1–7 5
3.2.2. Chlorin
The same PDT parameters for porphyrin were used for
Photodithazine. There was an evident reduction in the vascular
network (Fig. 5a). The peripheral blood vessels disappeared and
only the vessel of larger diameter in the deeper layers of the
CAM was still present. The mean reduction among the three eggs
was 59% ± 13%, calculating with graphs of Fig. 5b. This value was
higher than calculated for chlorin in topical application and they
are provided in Table 1.
The analysis of the vascular response depending on the vessel
diameter, for both photosensitizers, could not be performed due
to the impossibility of image analysis as a function of time.
The results show the intravenous injection was more effective
than the topical application. The direct injection in the vessel
showed no diffusion barrier confronted by the PS molecules in
the topical photosensitization.
In intravenous administration a more pronounced destruction
of vessels was observed when compared to topical application,
including vessels in deeper layers of the membrane. Even in vessels
that are not destroyed, a reduction in their diameters was observed
and, therefore it is considered the decreased vascular network as
overall effect.
4. Conclusions
The PDT vascular response in the CAM model depends on the
parameters used for porphyrin and chlorin. For the same photosen-
sitizer, the vascular response may be distinct, depending on the
photosensitization procedure (topical or intravenous), the drug-
light interval, and the PS concentration. Comparing the results,
the intravenous injection is the most efﬁcient photosensitization
method for the vascular PDT response and chlorin showed a higher
and faster effect.
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